An alternate model of tumoral progression.;Un modèle alternatif de progression tumorale

Biologie Aujourd'hui

Volumn 205, Issue 1, 2011, Pages 47-52

  Ansieau, Stéphane ^a   Puisieux, Alain ^a  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

Author keywords

Epithelio mesenchymal transition; Metastases; Tumoral progression; Twist proteins

Indexed keywords

EID: 79955083890     PISSN: 21050678     EISSN: 21050686     Source Type: Journal    
DOI: 10.1051/jbio/2011001     Document Type: Article

References (30)

1. Ansieau S., Bastid J., Doreau A., Morel A.P., Bouchet B.P., Thomas C., Fauvet F., Puisieux I., Doglioni C., Piccinin S., Maestro R., Voeltzel T., Selmi A., Valsesia-Wittmann S., Caron de F.C., Puisieux A., Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell, 2008a, 14, 79-89. (Pubitemid 351890463)
2. Ansieau S., Hinkal G., Thomas C., Bastid J., Puisieux A., Early origin of cancer metastases: dissemination and evolution of premalignant cells. Cell Cycle, 2008b, 7, 3659-3663.
3. Ansieau S., Morel A.P., Hinkal G., Bastid J., Puisieux A., TWISTing an embryonic transcription factor into an oncoprotein. Oncogene, 2010, 29, 3173-3184.
4. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Orntoft T., Lukas J., Bartek J., DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature, 2005, 434, 864-870. (Pubitemid 40558993)
5. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.V., Kolettas E., Niforou K., Zoumpourlis V.C., Takaoka M., Nakagawa H., Tort F., Fugger K., Johansson F., Sehested M., Andersen C.L., Dyrskjot L., Orntoft T., Lukas J., Kittas C., Helleday T., Halazonetis T.D., Bartek J., Gorgoulis V.G., Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature, 2006, 444, 633-637. (Pubitemid 44864442)
6. Battula V.L., Evans K.W., Hollier B.G., Shi Y., Marini F.C., Ayyanan A., Wang R.Y., Brisken C., Guerra R., Andreeff M., Mani S.A., Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells, 2010, 28, 1435-1445.
7. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H., Schlegelberger B., Stein H., Dorken B., Jenuwein T., Schmitt C.A., Oncogene-induced senescence as an initial barrier in lymphoma development. Nature, 2005, 436, 660-665. (Pubitemid 41117262)
8. Brosh R., Rotter V., When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer, 2009, 9, 701-713.
9. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., Benguria A., Zaballos A., Flores J.M., Barbacid M., Beach D., Serrano M., Tumour biology: senescence in premalignant tumours. Nature, 2005, 436, 642. (Pubitemid 41117258)
10. Creighton C.J., Li X., Landis M., Dixon J.M., Neumeister V.M., Sjolund A., Rimm D.L., Wong H., Rodriguez A., Herschkowitz J.I., Fan C., Zhang X., He X., Pavlick A., Gutierrez M.C., Renshaw L., Larionov A.A., Faratian D., Hilsenbeck S.G., Perou C.M., Lewis M.T., Rosen J.M., Chang J.C., Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA, 2009, 106, 13820-13825.
11. Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., Hancock D.C., Induction of apoptosis in fibroblasts by c-myc protein. Cell, 1992, 69, 119-128.
12. Gupta P.B., Onder T.T., Jiang G., Tao K., Kuperwasser C., Weinberg R.A., Lander E.S., Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell, 2009 138, 645-659.
13. Hermeking H., Eick D., Mediation of c-Myc-induced apoptosis by p53. Science, 1994, 265, 2091-2093.
14. Husemann Y., Geigl J.B., Schubert F., Musiani P., Meyer M., Burghart E., Forni G., Eils R., Fehm T., Riethmuller G., Klein C.A., Systemic spread is an early step in breast cancer. Cancer Cell, 2008, 13, 58-68. (Pubitemid 350309740)
15. Junttila M.R., Evan G.I., p53-a Jack of all trades but master of none. Nat Rev Cancer, 2009, 9, 821-829.
16. Klein C.A., Cancer. The metastasis cascade. Science, 2008, 321, 1785-1787.
17. Maestro R., Dei Tos A.P., Hamamori Y., Krasnokutsky S., Sartorelli V., Kedes L., Doglioni C., Beach D.H., Hannon G.J., Twist is a potential oncogene that inhibits apoptosis. Genes Dev, 1999, 13, 2207-2217. (Pubitemid 29426726)
18. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A., The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 2008, 133, 704-715. (Pubitemid 351636299)
19. Morel A.P., Lìevre M., Thomas C., Hinkal G., Ansieau S., Puisieux A., Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One, 2008, 3, e2888.
20. Ohashi S., Natsuizaka M., Wong G.S., Michaylira C.Z., Grugan K.D., Stairs D.B., Kalabis J., Vega M.E., Kalman R.A., Nakagawa M., Klein-Szanto A.J., Herlyn M., Diehl J.A., Rustgi A.K., Nakagawa H., Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelialto- mesenchymal transition through ZEB transcription factors1. Cancer Res, 2010, 70, 4174-4184.
21. Peinado H., Olmeda D., Cano A., Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer, 2008, 7, 415-428. (Pubitemid 46809165)
22. Schardt J.A., Meyer M., Hartmann C.H., Schubert F., Schmidt-Kittler O., Fuhrmann C., Polzer B., Petronio M., Eils R., Klein C.A., Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell, 2005, 8, 227-239. (Pubitemid 41317593)
23. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W., Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 1997, 88, 593-602. (Pubitemid 27152402)
24. Stoecklein N.H., Hosch S.B., Bezler M., Stern F., Hartmann C.H., Vay C., Siegmund A., Scheunemann P., Schurr P., Knoefel W.T., Verde P.E., Reichelt U., Erbersdobler A., Grau R., Ullrich A., Izbicki J.R., Klein C.A., Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell, 2008, 13, 441-453. (Pubitemid 351609446)
25. Thíery J.P., Acloque H., Huang R.Y., Nieto M.A., Epithelial-mesenchymal transitions in development and disease. Cell, 2009, 139, 871-890.
26. Thisse B., el Messal M., Perrin-Schmitt F., The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res, 1987, 15, 3439-3453.
27. Valsesia-Wittmann S., Magdeleine M., Dupasquier S., Garin E., Jallas A.C., Combaret V., Krause A., Leissner P., Puisieux A., Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell, 2004, 6, 625-630. (Pubitemid 40017705)
28. Vesuna F., Lisok A., Kimble B., Raman V., Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression1. Neoplasia, 2009, 11, 1318-1328.
29. Wang Z., Li Y., Ahmad A., Azmi A.S., Kong D., Banerjee S., Sarkar F.H., Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resist Update, 2010, In press.
30. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., Weinberg R.A., Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 2004, 117, 927-939. (Pubitemid 38798858)